Drug intelligence / Profile preview

Medi Super Joint

Development stage: Unknown
Lead developer: Medi-Crescent Pharma
Modality: Small Molecules
Administration: Oral

Overview

Medi Super Joint is an oral nutritional supplement distributed by Medi-Crescent Pharma, a pharmaceutical wholesaler and distributor based in Kenya. The product is marketed for joint health and support, specifically intended to provide relief for symptoms associated with osteoarthritis. As a nutraceutical, it is designed to support the structural integrity of joint tissues and improve mobility. While the specific formulation details are not publicly disclosed by the distributor, such joint support supplements typically contain a combination of ingredients such as glucosamine, chondroitin, or methylsulfonylmethane (MSM).

Brand names: Medi Super Joint

Beyond the preview

Go deeper on Medi Super Joint.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medi Super Joint.

Explore the full profile